HomeGenetics UnderstandingInheritanceWhy are some genetic conditions more common in particular ethnic groups?
Back to Inheritance
Why are some genetic conditions more common in particular ethnic groups?
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Inheritance

Why are some genetic conditions more common in particular ethnic groups?

Genetic disorders can appear more frequently in specific ethnic groups because members often share versions of genes passed down from common ancestors.

Overview

Some genetic disorders are more likely to occur among people who trace their ancestry to a particular geographic area. People in an ethnic group often share certain versions of their genes, which have been passed down from common ancestors. If one of these shared genes contains a disease-causing variant (also known as a mutation), a particular genetic disorder may be more frequently seen in that group.

Examples of Ethnic-Specific Conditions

It is important to note that while certain conditions are more common in specific populations, they can occur in any ethnic group. Examples include:

  • Sickle cell disease: More common in people of African, African American, or Mediterranean heritage.
  • Tay-Sachs disease: More likely to occur among people of Ashkenazi (eastern and central European) Jewish or French Canadian ancestry.

Frequently Asked Questions

Yes. Major medical organizations recommend prenatal carrier screening for conditions with higher carrier frequencies in specific ancestral groups, such as cystic fibrosis and spinal muscular atrophy for European ancestry, sickle cell disease for African or Mediterranean ancestry, and Tay-Sachs or Canavan disease for Ashkenazi Jewish ancestry. Many clinicians now use expanded carrier screening, which tests for hundreds of conditions simultaneously regardless of self-reported ethnicity, minimizing the chance of missing carrier status in individuals with diverse or unknown ancestry.
Self-identified race or ethnicity is a social category and does not always reflect biological genetic ancestry. If your ancestry is mixed or unknown, traditional ethnicity-targeted screening may overlook relevant risks. In clinical practice, providers increasingly rely on comprehensive pan-ethnic genetic panels that screen broadly across multiple conditions, and they look at individual clinical symptoms, family health histories, and targeted DNA sequencing rather than relying solely on ethnic background.
No. A reduced risk does not equal zero risk. Genetic mutations can spontaneously arise in any population, and human migration has dispersed genetic variants globally. For instance, cystic fibrosis can occur in individuals of Asian or African descent, and sickle cell disease can occur in individuals of northern European descent. Diagnostic testing should never be dismissed simply because a patient does not belong to the traditionally associated high-risk demographic.
Many harmful recessive mutations have persisted through natural selection because carrying a single copy provided a survival advantage against prevalent regional diseases, a concept called heterozygote advantage. For example, having one sickle cell gene variant protects against severe malaria infection in sub-Saharan Africa and the Mediterranean, allowing carriers to survive and reproduce. Similarly, historical geographic, religious, or cultural isolation often led to founder effects, where a small founding population passed down rare variants across generations within a closed community.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab